Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ebola Virus”

Showing 20 of 0 results

Not applicableUnknownNCT02333578
What this trial is testing

Clinical Trial to Evaluate the Efficacy and Safety of Convalescent Plasma for Ebola Treatment

Who this might be right for
Ebola Virus Disease
Clinical Research Management, Inc. 70
Early research (Phase 1)Study completedNCT02269423
What this trial is testing

Vaccine Treatment for Ebola Virus in Healthy Adults (V920-001)

Who this might be right for
Ebola Virus
Merck Sharp & Dohme LLC 39
Early research (Phase 1)Study completedNCT02313077
What this trial is testing

A Safety and Immunogenicity Study of Heterologous Prime-Boost Ebola Vaccine Regimens in Healthy Participants

Who this might be right for
Healthy
Crucell Holland BV 87
Early research (Phase 1)Study completedNCT02319772
What this trial is testing

Evaluate the Safety, Tolerability and Pharmacokinetics of BCX4430

Who this might be right for
Filovirus InfectionsEbola Virus Infection
BioCryst Pharmaceuticals 94
Testing effectiveness (Phase 2)Study completedNCT06036602
What this trial is testing

Monovalent Chimpanzee Adenoviral-Vectored Sudan Ebolavirus Vaccine in Healthy Adults

Who this might be right for
Ebola Sudan Virus Disease
Albert B. Sabin Vaccine Institute 125
Early research (Phase 1)Study completedNCT02267109
What this trial is testing

Phase 1 Trial of Ebola Vaccine in Mali

Who this might be right for
Ebola Virus DiseaseHemorrhagic Fever
University of Maryland, Baltimore 91
Large-scale testing (Phase 3)Study completedNCT02378753
What this trial is testing

STRIVE (Sierra Leone Trial to Introduce a Vaccine Against Ebola)

Who this might be right for
Hemorrhagic Fever, Ebola
Centers for Disease Control and Prevention 8,651
Early research (Phase 1)Study completedNCT02533791
What this trial is testing

A Booster Dose of Ad5-EBOV in Healthy Adults After Primary Immunization

Who this might be right for
Ebola Virus Disease
Jiangsu Province Centers for Disease Control and Prevention 110
Testing effectiveness (Phase 2)Study completedNCT02788227
What this trial is testing

Immunogenicity of Recombinant Vesicular Stomatitis Vaccine for Ebola-Zaire (rVSV∆G-ZEBOV-GP Vaccine)

Who this might be right for
Healthy Volunteers
National Institutes of Health Clinical Center (CC) 248
Early research (Phase 1)Study completedNCT02231866
What this trial is testing

Safety, Tolerability, and Immunogenicity of the Ebola Chimpanzee Adenovirus Vector Vaccine (cAd3-EBO), VRC-EBOADC069-00-VP, in Healthy Adults

Who this might be right for
Healthy Adult Immune Responses to Vaccine
National Institute of Allergy and Infectious Diseases (NIAID) 143
Post-approval studies (Phase 4)UnknownNCT06587503
What this trial is testing

Safety and Immunogenicity of rVSVΔG-ZEBOV-GP Vaccination When Dosed Concurrently With mRNA COVID-19 Vaccine Booster Doses

Who this might be right for
Ebola Virus DiseaseCOVID-19
University of Birmingham 72
Testing effectiveness (Phase 2)Study completedNCT02662855
What this trial is testing

Efficacy of Favipiravir Against Severe Ebola Virus Disease

Who this might be right for
Ebola Virus Disease
Beijing Institute of Pharmacology and Toxicology 77
Early research (Phase 1)Study completedNCT02280408
What this trial is testing

Safety and Immunogenicity of Prime-Boost Vesicular Stomatitis Virus (VSV) Ebola Vaccine in Healthy Adults (V920-002)

Who this might be right for
Ebola Viruses
Merck Sharp & Dohme LLC 39
Not applicableUnknownNCT04235361
What this trial is testing

Mobile Point of Care Diagnostic Testing for Ebola Virus Disease in DRC

Who this might be right for
Ebola Virus DiseaseMalariaTyphoid Fever+3 more
University of Stirling 500
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05202288
What this trial is testing

Impact of Delay Between Administration of Inmazeb Administration and Vaccination by Ervebo on Vaccine Immune Response on Healthy Volunteers

Who this might be right for
Ebola Virus Disease
ANRS, Emerging Infectious Diseases 132
Testing effectiveness (Phase 2)Study completedNCT03929757
What this trial is testing

2-dose Vaccination Regimen of Ad26.ZEBOV and MVA-BN-Filo in Infants

Who this might be right for
Ebola Virus Disease
Janssen Vaccines & Prevention B.V. 108
Not applicableStudy completedNCT02933931
What this trial is testing

Immune Durability After VSV-EBOV Vaccination

Who this might be right for
Immune ResponseVaccinationDurability
University Hospital, Geneva 95
Early research (Phase 1)Study completedNCT02376426
What this trial is testing

Evaluate the Safety and Immunogenicity of Heterologous Prime-Boost Ebola Vaccine Regimens in Healthy Participants

Who this might be right for
Healthy
Crucell Holland BV 72
Testing effectiveness (Phase 2)Study completedNCT02416453
What this trial is testing

Assess Safety, Tolerability, and Immunogenicity of Three Heterologus 2-dose Regimens of the Candidate Prophylactic Vaccines for Ebola in Healthy Adults

Who this might be right for
Ebola Viral Disease
Janssen Vaccines & Prevention B.V. 423
Not applicableStudy completedNCT06811129
What this trial is testing

Long-Term Neurologic and Neurocognitive Sequelae Following Pediatric Ebola Virus in Liberia

Who this might be right for
EbolaPost-Acute Ebola Syndrome
National Institute of Neurological Disorders and Stroke (NINDS) 328
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation